The Angels' Forum

The Angels' Forum LLC is a venture capital firm based in Redwood City, California, that focuses on seed and early-stage investments in the San Francisco Bay Area and Silicon Valley. Founded in 1997 by Carol Sands, the firm specializes in disruptive technologies, targeting sectors such as software, information technology, life sciences, and consumer products. The Angels' Forum typically invests between $0.1 million and $1 million in companies that are often seeking Series A financing, with the potential for follow-on investments in subsequent rounds. The firm has a preference for companies headquartered within 50 miles of Mountain View and generally collaborates with other venture funds for co-investments. While it does not typically take a board seat, it may seek observation rights in its portfolio companies. The firm invests in a select number of companies each year, focusing on leveraging its expertise in technology and life sciences to support innovative startups.

Klaus Hambuechen

Partner and Investor

41 past transactions

VIDA

Series C in 2020
VIDA is a lung health company that modernizes respiratory care by leveraging artificial intelligence to enhance patient outcomes and streamline care coordination. The company provides healthcare organizations and physicians with advanced quantitative data intelligence and impactful visualizations, enabling effective management of patients with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and COVID-19. VIDA's software is FDA cleared, CE-marked, Health Canada licensed, and TGA registered, allowing for clinical use in the United States, European Economic Area, Canada, and Australia. Additionally, VIDA offers a comprehensive suite of clinical trial services, which includes advanced quantitative image analysis and support for trial data enhancement, site quality services, and subject screening, thus contributing to the acceleration of new therapies for patients.

Halio

Series C in 2017
Halio is a manufacturer of advanced smart-tinting glass that dynamically responds to changing light conditions, transforming architectural elements such as windows, walls, and skylights. The company's technology allows the glass to transition from clear to tinted or dark, either automatically or on command, enhancing the efficiency and aesthetics of buildings and homes. Halio's glass tints up to ten times faster than traditional electrochromic glass, providing uniform tinting without color distortion. This innovation not only offers shade and glare relief but also allows for unlimited tint level options, resulting in unprecedented comfort and control over indoor environments. Additionally, Halio's software and hardware controls seamlessly integrate with building management systems, while its manufacturing techniques ensure reliable on-time deliveries, aligning with industry standards. Overall, Halio aims to enhance the living and working experience through its cutting-edge glass solutions.

OneMob

Venture Round in 2017
OneMob, Inc. is a San Francisco-based company that provides a communications platform focused on personalizing customer interactions. It enables businesses to enhance their sales and marketing efforts through a video and voice messaging platform, allowing sales, customer success, and support representatives to create and send personalized, branded, and trackable video and voice messages. The platform features innovative tools such as microsites for consolidating personalized content, digital sales rooms for collaborative buyer interactions, and video prospecting capabilities to engage potential clients effectively. OneMob also integrates AI-powered tools for video creation and writing assistance, enabling users to produce professional-grade communications easily. With features like dynamic templates, advanced video editing, and CRM integrations, OneMob supports efficient outreach while ensuring a personal touch. The company has earned recognition from various industry analysts and serves notable enterprise clients, reinforcing its reputation as a leader in sales and marketing enablement.

Kiana Analytics

Series A in 2017
Kiana Analytics, Inc. is a technology company that specializes in cloud-based device detection and customer analytics software for various industries, including retail, restaurant, and event management. Founded in 2013 and based in Sunnyvale, California, Kiana Analytics develops its flagship solution, Presence Analytics, which enhances store performance and sales conversion by analyzing customer traffic and behavior prior to the point of sale. Utilizing Wi-Fi fingerprints from customer smartphones, the software detects customer presence and tracks movements within physical spaces, enabling businesses to gain insights into customer patterns. The company emphasizes a privacy-centered approach in its operations, offering tools that improve physical safety and security while ensuring an optimal experience for employees and visitors.

Glue Networks

Venture Round in 2017
Glue Networks specializes in providing an enterprise-grade cloud networking service. Glue Virtual Office is available to enterprise customers through partnerships between Glue Networks and top service providers and value-added resellers. It was founded in 2007 and headquartered in Sacramento, California.

Hospi

Venture Round in 2017
Hospi Corporation is a medical device company based in Newark, California, that specializes in developing innovative solutions for patients with serious or terminal illnesses and their caregivers. Founded in 2012, the company focuses on enhancing patient comfort and wellbeing while easing caregiver burdens. Its flagship product, the Macy Catheter, is designed for the discreet rectal administration of liquids or medications, addressing a critical need in hospice and palliative care settings. The Macy Catheter features a dual port and dual lumen design, allowing for effective retention and ease of use. Additionally, Hospi offers the Liquipill system for preparing medication suspensions and the Macy Catheter Bedside Care Kit, which includes necessary tools for clinicians. The company’s products have received regulatory clearance from the U.S. Food and Drug Administration, reflecting its commitment to quality and safety in patient care.

Chimera Bioengineering

Venture Round in 2016
Chimera Bioengineering is a biotechnology company focused on developing innovative gene therapeutics aimed at reprogramming the immune system to combat cancer. The company specializes in chimeric antigen receptor T-cells (CARs), which are engineered immune cells designed to bypass the immune evasion mechanisms employed by tumors. While CAR therapies have demonstrated significant success in treating liquid tumors, challenges remain in addressing solid tumors, including limited efficacy and potential toxicities. To overcome these obstacles, Chimera Bioengineering utilizes drug-responsive gene regulators to optimize CAR functionality. This approach enhances the ability of immune cells to target and eliminate tumor cells that express specific antigens, ultimately aiming to improve patient outcomes and reduce adverse effects. Through these advancements, Chimera Bioengineering aspires to offer effective solutions for patients who have not responded to conventional cancer treatments.

Sonoma Orthopedic Products

Venture Round in 2016
Sonoma Orthopedic Products is an orthopedic device company focused on designing, developing, and delivering proprietary orthopedic implants to address complex fractures. Utilizing the WaviBody technology platform, the company provides innovative surgical solutions that are minimally invasive, catering specifically to active patients. The firm specializes in fracture fixation devices that facilitate the repair of challenging bone geometries, enabling orthopedic surgeons to effectively restore function and return patients to their daily activities more rapidly. By prioritizing ease of use and efficacy in their products, Sonoma Orthopedic Products aims to enhance the recovery process for individuals with problematic fractures.

Glue Networks

Venture Round in 2016
Glue Networks specializes in providing an enterprise-grade cloud networking service. Glue Virtual Office is available to enterprise customers through partnerships between Glue Networks and top service providers and value-added resellers. It was founded in 2007 and headquartered in Sacramento, California.

The Detection Group

Venture Round in 2016
The Detection Group, Inc. is a technology company specializing in advanced monitoring and alarm solutions designed to protect commercial and residential properties from water leaks. Founded in 2006, the company developed its innovative leak detection system, which provides continuous monitoring of potential water leak sources and responds to incidents by sounding alarms, notifying designated individuals, and shutting off water supply when necessary. This system not only reduces the risk of water damage and associated costs but also helps track response times, serving as a valuable tool for insurance purposes. The Detection Group's solutions cater to commercial property managers, multi-story residential property managers, and insurance providers. The company operates through a network of dealers across several states, including Maryland, New Jersey, New York, California, and Massachusetts, and is headquartered in Palo Alto, California, with an additional office in San Diego.

SupportPay

Venture Round in 2016
SupportPay is a payment platform designed to assist single, divorced, separated, and blended families in managing their financial relationships. The platform enables users to share, manage, and track expenses, payments, and schedules related to child support. Through its application, parents can easily track expenses, store receipts, dispute items, and facilitate payments directly between one another. SupportPay is accessible to consumers and can also be offered as an employee benefit, providing a comprehensive solution for families navigating the complexities of financial arrangements. The company is owned by Smart Family Tech, Inc., which acquired its assets following the liquidation of its predecessor, Ittavi, Inc.

RenovoRx

Series C in 2015
RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. The company focuses on innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. Its flagship product, RenovoCath, is an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to improve therapeutic outcomes, particularly for cancer patients, through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while reducing potential toxicities associated with systemic therapies. Supported by a team of experienced management and a diverse Advisory Board of medical professionals, RenovoRx is committed to advancing its clinical development strategies and addressing high unmet medical needs in cancer treatment.

DecisionNext

Seed Round in 2015
DecisionNext, Inc. is a San Francisco-based company that offers a cloud-based predictive analytics platform tailored for commodities-driven industries, including minerals, agribusiness, fishing, forestry, oil, and gas. Founded in 2013, DecisionNext's platform utilizes proprietary machine learning algorithms to deliver real-time forecasting, market scenario simulations, and decision validation. Its solutions encompass various optimization areas, such as commodity price forecasting, purchasing, product mix, capacity, and pricing strategies. By integrating these optimizations into a cohesive system, DecisionNext enables its clients to enhance their decision-making processes, maximize profit margins, and reduce uncertainties, thereby gaining a significant competitive advantage. The company also maintains an office in Brisbane, Australia.

Zephyrus Biosciences

Seed Round in 2014
Zephyrus Biosciences, Inc. is a life science research tools company based in Berkeley, California, founded in 2013. The company specializes in developing and commercializing innovative tools for protein analysis at the single-cell level. Its flagship product, the scWestern System, allows for western blotting on individual cells, a significant advancement in the field of single-cell analysis. By utilizing microfluidics technology, the scWestern system partitions single cells into micro-wells, lyses them, and performs SDS-PAGE separation on each cell lysate. This technology facilitates the identification of cellular subpopulations, the analysis of enriched cell populations post-FACS sorting, and studies on cell signaling and cancer heterogeneity, among other applications. Researchers leverage Zephyrus's products to gain deeper insights into various biological fields, including cancer, stem cells, neurology, and human disease development, ultimately aiming to enhance healthcare outcomes.

Gemmus Pharma

Series B in 2014
Gemmus Pharma Inc., established in 2007 and headquartered in San Francisco, California, is a biotechnology company focused on developing therapeutics for the treatment of influenza and other infectious diseases. The company's primary product candidates are GP1001 and GP1681. GP1001, a non-peptidic eiconsanoid analog, is intended for treating severe influenza infections requiring hospitalization, serving as either a standalone therapy or in combination with antiviral drugs like oseltamivir. Meanwhile, GP1681 aims to alleviate influenza symptoms by moderating the viral-induced cytokine response. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Diseases (NIAID) and plans to submit an Investigational New Drug (IND) application to the FDA for its influenza treatment in 2014.

RenovoRx

Series B in 2014
RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. The company focuses on innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. Its flagship product, RenovoCath, is an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to improve therapeutic outcomes, particularly for cancer patients, through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while reducing potential toxicities associated with systemic therapies. Supported by a team of experienced management and a diverse Advisory Board of medical professionals, RenovoRx is committed to advancing its clinical development strategies and addressing high unmet medical needs in cancer treatment.

Scopix

Series A in 2012
Scopix is a leading provider of intelligent video analytics specifically tailored for retailers, consumer packaged goods (CPG) companies, and manufacturers. The company offers a cloud-based platform that collects and analyzes data, delivering actionable insights through a web-based portal for store personnel, regional managers, and corporate executives. Scopix's Real.Suite family of solutions enables businesses to enhance customer experience by measuring key performance indicators such as staff performance, customer feedback, and queue lengths. These tools are designed to improve retail operations, drive sales, and ultimately maximize profits, ensuring that retailers can adapt quickly to customer needs and market trends.

Intrapace

Venture Round in 2012
IntraPace, Inc. is a medical device company focused on developing innovative solutions for obesity treatment. Founded in 2001 and headquartered in Mountain View, California, the company has created the abiliti system, an implantable device that stimulates a satiety response to assist patients in achieving weight loss. This device utilizes established technology similar to that found in cardiac pacemakers and defibrillators. The abiliti system is designed for implantation using standard laparoscopic techniques, allowing for a minimally invasive procedure that does not alter the anatomy of the digestive system or restrict dietary choices.

Gemmus Pharma

Series A in 2012
Gemmus Pharma Inc., established in 2007 and headquartered in San Francisco, California, is a biotechnology company focused on developing therapeutics for the treatment of influenza and other infectious diseases. The company's primary product candidates are GP1001 and GP1681. GP1001, a non-peptidic eiconsanoid analog, is intended for treating severe influenza infections requiring hospitalization, serving as either a standalone therapy or in combination with antiviral drugs like oseltamivir. Meanwhile, GP1681 aims to alleviate influenza symptoms by moderating the viral-induced cytokine response. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Diseases (NIAID) and plans to submit an Investigational New Drug (IND) application to the FDA for its influenza treatment in 2014.

Turpitude

Series A in 2011
Turpitude provides clients, including developers, publishers and property holders, with AAA game design consulting services along with creating games as well.

OncoHealth

Series A in 2011
OncoHealth is a company that specializes in the development of screening devices aimed at detecting and diagnosing cancer. Its innovative technology focuses on the creation of protein bio-markers specifically for the screening and diagnostics of cervical cancer and other cancers associated with the human papillomavirus (HPV). By providing advanced tools for medical professionals, OncoHealth enhances the ability to monitor, diagnose, and treat cancer, ultimately contributing to improved patient outcomes in oncology.

Taulia

Series A in 2010
Taulia, established in 2009, is a global FinTech company specializing in supply chain management and financing software. Headquartered in San Francisco with offices worldwide, Taulia offers AI-driven solutions for both buyers and suppliers. For buyers, Taulia provides dynamic discounting, supply chain finance, cash forecasting, invoice automation, and supplier management tools. For suppliers, it offers early payment, electronic invoicing, and self-service platforms. Taulia's cloud-based solutions enable businesses to transform every invoice into a revenue opportunity, streamline e-invoicing, and empower suppliers, ultimately enhancing working capital management. The company has a strategic alliance with KPMG.

Qumu

Debt Financing in 2010
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

Bella Pictures

Debt Financing in 2009
Bella Pictures, established in 2003 and based in San Francisco, California, specializes in wedding photography and videography. The company offers a range of services including expert advice, various album options, and additional features to enhance the wedding experience. Bella Pictures is known for providing affordable, high-quality photography packages tailored for weddings.

Qumu

Series C in 2008
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

MOG

Series C in 2008
MOG Inc. is a music media company founded in June 2005 by David Hyman, who previously served as CEO of Gracenote. The company aims to enhance the music listening experience through its on-demand streaming service, which offers access to a vast library of over 14 million songs from more than a million albums. MOG's platform is available across multiple devices, including mobile apps for iPhone and Android, desktop applications for Mac and Windows, and streaming devices like Roku and Sonos. It is recognized for its user-friendly interface, discovery features, and high audio quality. Additionally, MOG operates The MOG Music Network, a leading platform for music content online and the largest advertising network focused on music, attracting over 60 million unique visitors monthly. Headquartered in Berkeley, California, MOG has attracted investments from notable firms and individuals, including Menlo Ventures and Rick Rubin, who serves on its Board of Directors.

Podaddies

Angel Round in 2007
Podaddies, Inc. is a San Francisco-based company specializing in online video advertising technology. Founded in 2006, it offers a proprietary platform that enables marketers to integrate advertisements into both streamed and downloaded video content. The company's in-stream video advertising technology allows for real-time insertion of ads, facilitating targeted campaigns that can be monitored and optimized for performance. Podaddies serves a diverse clientele including content publishers, social networks, podcasters, and app developers, providing them with tools for viewer, contextual, and behavioral targeting. Additionally, the company supports agencies and video consumers in navigating the advertising landscape effectively. With a focus on delivering high-quality, measurable advertising solutions, Podaddies aims to connect advertisers with their target audiences across various platforms.

MOG

Series B in 2007
MOG Inc. is a music media company founded in June 2005 by David Hyman, who previously served as CEO of Gracenote. The company aims to enhance the music listening experience through its on-demand streaming service, which offers access to a vast library of over 14 million songs from more than a million albums. MOG's platform is available across multiple devices, including mobile apps for iPhone and Android, desktop applications for Mac and Windows, and streaming devices like Roku and Sonos. It is recognized for its user-friendly interface, discovery features, and high audio quality. Additionally, MOG operates The MOG Music Network, a leading platform for music content online and the largest advertising network focused on music, attracting over 60 million unique visitors monthly. Headquartered in Berkeley, California, MOG has attracted investments from notable firms and individuals, including Menlo Ventures and Rick Rubin, who serves on its Board of Directors.

Sonoma Orthopedic Products

Series B in 2007
Sonoma Orthopedic Products is an orthopedic device company focused on designing, developing, and delivering proprietary orthopedic implants to address complex fractures. Utilizing the WaviBody technology platform, the company provides innovative surgical solutions that are minimally invasive, catering specifically to active patients. The firm specializes in fracture fixation devices that facilitate the repair of challenging bone geometries, enabling orthopedic surgeons to effectively restore function and return patients to their daily activities more rapidly. By prioritizing ease of use and efficacy in their products, Sonoma Orthopedic Products aims to enhance the recovery process for individuals with problematic fractures.

Catalist Homes

Series D in 2007
Catalist Homes is a real estate company providing a higher quality of client service through professional personnel working out of local offices and backed with tremendous corporate support. A reduction in fees would be meaningless if your home did not achieve its maximum value on the market. The good news for CataList Home's clients is they not only save thousands of dollars in fees, but yield higher prices and almost identical marketing times than other homes sold in the market. Data from hundreds of CataList sales in Los Angeles and Orange County prove that they achieve the highest sold price to listing price The truth is, it does not cost any real estate agent more than 3% to sell a home. Fees in excess of 3% represent an excessive charge to the home seller for the use of a real estate agent involved in an old, inefficient and costly system. Instead, you should be asking: "How can Realtors continue to charge five and six percent commissions (typically eliminating 20-25% of homeowner equity) when the average home is sold in less than 30 days?" When you consider the fact that home prices have virtually doubled in the last five years, how can Realtors keep the commission percentage the same and essentially double their fee? Your conventional agent is asking you for a 100% pay raise in 5 years, and he wants you to pay for it. A 3% commission in 2006 is the same dollar cost as 6% just five years ago when you factor in home appreciation. This is how they offer all the essential service for 3%.

Sonoma Orthopedic Products

Series A in 2007
Sonoma Orthopedic Products is an orthopedic device company focused on designing, developing, and delivering proprietary orthopedic implants to address complex fractures. Utilizing the WaviBody technology platform, the company provides innovative surgical solutions that are minimally invasive, catering specifically to active patients. The firm specializes in fracture fixation devices that facilitate the repair of challenging bone geometries, enabling orthopedic surgeons to effectively restore function and return patients to their daily activities more rapidly. By prioritizing ease of use and efficacy in their products, Sonoma Orthopedic Products aims to enhance the recovery process for individuals with problematic fractures.

Mobile Content Networks

Series A in 2006
MCN (Mobile Content Networks) provides mobile search management and revenue solutions that connect mobile users directly to the content they seek while delivering profitable new revenue streams for operators and content providers. MCN is led by an experienced, global management team and backed by some of the most successful venture capital firms in the U.S. and Japan. Before launching the company in 2004, MCN conducted a multi-year study of the unique characteristics of the mobile commerce ecosystem. Equipped with a thorough understanding of the industry’s unique needs, MCN pioneered real-time federated search management, as well as the mobile industry’s highest performing paid search program, allwords.

Qumu

Series B in 2006
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

MOG

Series A in 2006
MOG Inc. is a music media company founded in June 2005 by David Hyman, who previously served as CEO of Gracenote. The company aims to enhance the music listening experience through its on-demand streaming service, which offers access to a vast library of over 14 million songs from more than a million albums. MOG's platform is available across multiple devices, including mobile apps for iPhone and Android, desktop applications for Mac and Windows, and streaming devices like Roku and Sonos. It is recognized for its user-friendly interface, discovery features, and high audio quality. Additionally, MOG operates The MOG Music Network, a leading platform for music content online and the largest advertising network focused on music, attracting over 60 million unique visitors monthly. Headquartered in Berkeley, California, MOG has attracted investments from notable firms and individuals, including Menlo Ventures and Rick Rubin, who serves on its Board of Directors.

Modviz

Seed Round in 2004
Modviz is a company that specializes in virtual graphics solutions for data visualization. It offers software that assists organizations in visualizing large 3D data sets on computing clusters, facilitating the analysis and interpretation of complex data. In addition to its visualization software, Modviz provides a 3D graphics computing platform that supports custom OpenGL applications, enabling clients to tailor their data visualization needs. The company's focus on advanced graphics technology positions it as a key player in the realm of data visualization, catering to the growing demand for efficient and effective data analysis tools.

Clairvoyante

Series B in 2004
Clairvoyante develops PenTile RGBW technology to optimize screen brightness, resolution, and power consumption of flat-panel liquid crystal displays that enables high-brightness and low-power displays that needs to support data-centric 3G applications and contents. Clairvoyante is a U.S.-based company that was founded in 2000 by Candice Brown Elliott. The company was acquired by Samsung Electronics on March, 2008.

NeoGuide Systems

Series B in 2003
NeoGuide Systems Inc. is a developer of robotic endoscopic technology specifically designed for natural orifice transluminal endoscopic surgery (NOTES). Founded in 2000 and based in San Jose, California, the company focuses on creating advanced solutions for medical procedures, particularly in colonoscopy applications. Its innovative technology aims to enhance the visualization and delivery of therapies within the body, thereby improving access to abdominal and thoracic cavities. NeoGuide is positioned at the forefront of a transformative approach in minimally invasive surgery, contributing to the evolution of medical practices in the field.

Media Publisher

Series A in 2003
Media Publisher, Inc. (MPI) is the leader in Enterprise Video Communication, enabling Fortune 2000 companies to UNIFY content from a wide array of content providers and file types, CREATE live and on-demand video presentations, MANAGE video assets in a scalable and robust EVC platform, and DELIVER video content to an organization's existing network and computing infrastructure. Media Publisher Solutions offer significant value to the enterprise in Corporate Communications, Sales and Channel Enablement, and Engineering/R&D Distance Learning. Many large-scale, international customers have adopted Media Publisher Solutions to drive significant revenue generation benefits across the enterprise. Additionally, Media Publisher leverages past infrasturucture investments to deliver dramatic efficiency-gain and productivity benefits. Business video delivered via the internet is now a reliable and cost-effective communications tool for the enterprise. Corporate networks, video software applications, and enterprise infrastructure have matured to allow companies to broadcast streaming video presentations cost-effectively and easily without expensive proprietary hardware or satellite networks. Far more compelling than audio or web conferences, broadcast video helps companies communicate more effectively, improve productivity, and cut costs. Media Publisher enterprise software eliminates much of the technical complexity involved in creating, broadcasting and managing business video. Their products help large organizations remove IT as a process bottleneck while allowing IT to maintain control of their infrastructure and enabling even non-technical employees to fully utilize business video publishing and management tools. Enterprise-class and fully deployed and tested in eight of the Fortune 50, Media Publisher 4.0 is helping companies make broadcast video communications over IP a mission critical application.

Qumu

Series A in 2003
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

AirPrime

Series B in 2000
The company develops code division multiple access chipsets for wireless voice and data products.

YY Technologies

Venture Round in 2000
YY is the world leader in Natural Language Processing technology, offering software that enables computers to really understand language as people naturally speak or write it. This means that YY software understands: - Full sentences, not just keywords and menu choices - Multiple sentences and multiple topics in the same message - Sentences with incorrect grammar, structure, spelling or punctuation - Either text or voice input YY software translates natural language sentences and paragraphs to detailed XML instructions, thus enabling written or spoken natural language to be the interface to a variety of database and other applications. With YY, automatic machine-generated responses are 99% accurate the first time, are generated within 60 seconds of the input, and include order processing information, embedded links to relevant documents, and other data relevant to responding to the user's need.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.